Cargando…
A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables
Abundant evidence has indicated that the prognosis of cutaneous melanoma (CM) patients is highly complicated by the tumour immune microenvironment. We retrieved the clinical data and gene expression data of CM patients in The Cancer Genome Atlas (TCGA) database for modelling and validation analysis....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701680/ https://www.ncbi.nlm.nih.gov/pubmed/36437242 http://dx.doi.org/10.1038/s41598-022-23475-4 |
_version_ | 1784839587073359872 |
---|---|
author | Tang, Yifan Feng, Huicong Zhang, Lupeng Qu, Chiwen Li, Jinlong Deng, Xiangyu Zhong, Suye Yang, Jun Deng, Xiyun Zeng, Xiaomin Wang, Yiren Peng, Xiaoning |
author_facet | Tang, Yifan Feng, Huicong Zhang, Lupeng Qu, Chiwen Li, Jinlong Deng, Xiangyu Zhong, Suye Yang, Jun Deng, Xiyun Zeng, Xiaomin Wang, Yiren Peng, Xiaoning |
author_sort | Tang, Yifan |
collection | PubMed |
description | Abundant evidence has indicated that the prognosis of cutaneous melanoma (CM) patients is highly complicated by the tumour immune microenvironment. We retrieved the clinical data and gene expression data of CM patients in The Cancer Genome Atlas (TCGA) database for modelling and validation analysis. Based on single-sample gene set enrichment analysis (ssGSEA) and consensus clustering analysis, CM patients were classified into three immune level groups, and the differences in the tumour immune microenvironment and clinical characteristics were evaluated. Seven immune-related CM prognostic molecules, including three mRNAs (SUCO, BTN3A1 and TBC1D2), three lncRNAs (HLA-DQB1-AS1, C9orf139 and C22orf34) and one miRNA (hsa-miR-17-5p), were screened by differential expression analysis, ceRNA network analysis, LASSO Cox regression analysis and univariate Cox regression analysis. Their biological functions were mainly concentrated in the phospholipid metabolic process, transcription regulator complex, protein serine/threonine kinase activity and MAPK signalling pathway. We established a novel prognostic model for CM integrating clinical variables and immune molecules that showed promising predictive performance demonstrated by receiver operating characteristic curves (AUC ≥ 0.74), providing a scientific basis for predicting the prognosis and improving the clinical outcomes of CM patients. |
format | Online Article Text |
id | pubmed-9701680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97016802022-11-29 A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables Tang, Yifan Feng, Huicong Zhang, Lupeng Qu, Chiwen Li, Jinlong Deng, Xiangyu Zhong, Suye Yang, Jun Deng, Xiyun Zeng, Xiaomin Wang, Yiren Peng, Xiaoning Sci Rep Article Abundant evidence has indicated that the prognosis of cutaneous melanoma (CM) patients is highly complicated by the tumour immune microenvironment. We retrieved the clinical data and gene expression data of CM patients in The Cancer Genome Atlas (TCGA) database for modelling and validation analysis. Based on single-sample gene set enrichment analysis (ssGSEA) and consensus clustering analysis, CM patients were classified into three immune level groups, and the differences in the tumour immune microenvironment and clinical characteristics were evaluated. Seven immune-related CM prognostic molecules, including three mRNAs (SUCO, BTN3A1 and TBC1D2), three lncRNAs (HLA-DQB1-AS1, C9orf139 and C22orf34) and one miRNA (hsa-miR-17-5p), were screened by differential expression analysis, ceRNA network analysis, LASSO Cox regression analysis and univariate Cox regression analysis. Their biological functions were mainly concentrated in the phospholipid metabolic process, transcription regulator complex, protein serine/threonine kinase activity and MAPK signalling pathway. We established a novel prognostic model for CM integrating clinical variables and immune molecules that showed promising predictive performance demonstrated by receiver operating characteristic curves (AUC ≥ 0.74), providing a scientific basis for predicting the prognosis and improving the clinical outcomes of CM patients. Nature Publishing Group UK 2022-11-27 /pmc/articles/PMC9701680/ /pubmed/36437242 http://dx.doi.org/10.1038/s41598-022-23475-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tang, Yifan Feng, Huicong Zhang, Lupeng Qu, Chiwen Li, Jinlong Deng, Xiangyu Zhong, Suye Yang, Jun Deng, Xiyun Zeng, Xiaomin Wang, Yiren Peng, Xiaoning A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title | A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title_full | A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title_fullStr | A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title_full_unstemmed | A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title_short | A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
title_sort | novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701680/ https://www.ncbi.nlm.nih.gov/pubmed/36437242 http://dx.doi.org/10.1038/s41598-022-23475-4 |
work_keys_str_mv | AT tangyifan anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT fenghuicong anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zhanglupeng anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT quchiwen anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT lijinlong anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT dengxiangyu anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zhongsuye anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT yangjun anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT dengxiyun anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zengxiaomin anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT wangyiren anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT pengxiaoning anovelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT tangyifan novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT fenghuicong novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zhanglupeng novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT quchiwen novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT lijinlong novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT dengxiangyu novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zhongsuye novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT yangjun novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT dengxiyun novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT zengxiaomin novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT wangyiren novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables AT pengxiaoning novelprognosticmodelforcutaneousmelanomabasedonanimmunerelatedgenesignatureandclinicalvariables |